Search Science Hub

Science Hub is Novo Nordisk’s one-stop portal for all our scientific publications and clinical trials, congress materials and medical updates. Sign up to gain full access.

Welcome to Novo Nordisk Science Hub

Are you a healthcare professional?

ADA 2026 5 - 8 June 2026

Impact of Once-Weekly Injectable Semaglutide Versus Placebo on Fatty Liver Index Scores in People with Overweight/Obesity: A Post Hoc Analysis (STEP 1)

Authors :

Gema Frühbeck¹; Maximilian Jara²; Naveen Rathor³; Jonathan Sudkamp⁴; Lauren Wilson²

Affiliations

View Details Hide Details

Download .PDF

Keywords

Obesity

Congress poster

GLP-1 RA

Semaglutide

RWE HEOR